Treatment Of Leucoderma By Ammi Visnaga
Phase 4
- Conditions
- Health Condition 1: L815- Leukoderma, not elsewhere classified
- Registration Number
- CTRI/2023/06/053856
- Lead Sponsor
- RBTS Government Homoeopathic Medical College And Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All age groups
Self reported and pre diagnosed cases of Leucoderma
Patients with signs and symptomatology of Leucoderma
Cases confirmed by Woods lamp examination
Exclusion Criteria
Patients or its guardian unwilling to take part or not giving consent to join the study
Diagnosed cases of systemic diseases psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure
Age less than 06 months
Substance abuse or dependence
Self reported immune compromised state
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in their symptomatology. <br/ ><br>Improvement in Vitiligo Area Scoring Index VASITimepoint: 1 month to 3 months
- Secondary Outcome Measures
Name Time Method Improvement in their symptomatology <br/ ><br>Improvement in Vitiligo Disease Activity <br/ ><br>Score VIDA <br/ ><br>Improvement in DLQI Score <br/ ><br>Timepoint: 3 to 6 months